![Demand for AI-powered tools to accelerate drug discovery and research has risen across pharmaceutical companies, academic institutions and biotech firms [File]](https://www.thehindu.com/theme/images/th-online/1x1_spacer.png "Demand for AI-powered tools to accelerate drug discovery and research has risen across pharmaceutical companies, academic institutions and biotech firms [File]")
OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research capabilities, as the startup deepens its push into the life sciences field.
The GPT-Rosalind, named after 20th-century British scientist Rosalind Franklin, is designed to support research across biochemistry, drug discovery and translational medicine.